Physician profile
Wei Tan
NPI 1083057384
$5,973.24
in general payments reported to CMS, 2019-2025
17 companies · $2,404 in 2025
The $2,404 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2022: $150 · 2023: $1,453 · 2024: $1,758 · 2025: $2,404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,934 · Consulting Fee: $865 · Travel and Lodging: $816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,934.12 |
| Consulting Fee | $865.00 |
| Travel and Lodging | $816.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $1,933.09 | 2023-2025 | Focal One |
| Palette Life Sciences, INC. | $1,185.21 | 2023 | |
| Becton, Dickinson and Company | $800.00 | 2025 | |
| Agiliti Surgical, INC. | $540.62 | 2023-2025 | Koelis Trinity Fusion Biopsy System, Endocare Cryocare Cs System, Siemens Healthineers Varian Cryocare |
| Janssen Scientific Affairs, LLC | $351.09 | 2025 | Erleada, Balversa |
| Ferring Pharmaceuticals INC. | $220.08 | 2024-2025 | Adstiladrin |
| Boston Scientific Corporation | $185.12 | 2019-2024 | Spaceoar Vue System - 10ml |
| Blue Earth Diagnostics | $177.85 | 2025 | Posluma |
| Koelis INC. | $150.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $149.70 | 2024 | |
| Medtronic, INC. | $87.83 | 2023-2025 | Ta, Eea, Endo Clip III |
| Merck Sharp & Dohme LLC | $43.50 | 2019 | |
| Novo Nordisk INC | $42.93 | 2024 | |
| Civco Medical Instruments | $38.96 | 2025 | |
| Dentsply Ih Ab | $24.88 | 2023 | Lofric |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $24.21 | 2024 | |
| Abbvie INC. | $18.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wei Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.